GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zeo ScientifiX Inc (OTCPK:ZEOX) » Definitions » Cyclically Adjusted PB Ratio

ZEOX (Zeo ScientifiX) Cyclically Adjusted PB Ratio : (As of May. 29, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Zeo ScientifiX Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Zeo ScientifiX Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Zeo ScientifiX's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zeo ScientifiX Cyclically Adjusted PB Ratio Chart

Zeo ScientifiX Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zeo ScientifiX Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Zeo ScientifiX's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Zeo ScientifiX's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zeo ScientifiX's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zeo ScientifiX's Cyclically Adjusted PB Ratio falls into.


;
;

Zeo ScientifiX Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Zeo ScientifiX's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2025 is calculated as:

For example, Zeo ScientifiX's adjusted Book Value per Share data for the three months ended in Jan. 2025 was:

Adj_Book=Book Value per Share/CPI of Jan. 2025 (Change)*Current CPI (Jan. 2025)
=-0.284/134.0288*134.0288
=-0.284

Current CPI (Jan. 2025) = 134.0288.

Zeo ScientifiX Quarterly Data

Book Value per Share CPI Adj_Book
201504 -0.067 99.824 -0.090
201507 -0.741 100.691 -0.986
201510 0.026 100.346 0.035
201601 -0.567 99.957 -0.760
201604 -0.682 100.947 -0.906
201607 -0.930 101.524 -1.228
201610 -1.503 101.988 -1.975
201701 -2.640 102.456 -3.454
201704 -3.703 103.167 -4.811
201707 -4.865 103.278 -6.314
201710 -6.386 104.070 -8.224
201801 -6.128 104.578 -7.854
201804 -0.280 105.708 -0.355
201807 -0.400 106.324 -0.504
201810 -0.577 106.695 -0.725
201901 -0.651 106.200 -0.822
201904 -0.627 107.818 -0.779
201907 -0.555 108.250 -0.687
201910 -0.621 108.577 -0.767
202001 -0.826 108.841 -1.017
202004 -0.615 108.173 -0.762
202007 -0.490 109.318 -0.601
202010 -0.296 109.861 -0.361
202101 -0.570 110.364 -0.692
202104 -0.460 112.673 -0.547
202107 -0.441 115.183 -0.513
202110 -0.471 116.696 -0.541
202201 -0.572 118.619 -0.646
202204 -0.718 121.978 -0.789
202207 -0.765 125.002 -0.820
202210 0.255 125.734 0.272
202301 0.091 126.223 0.097
202304 -0.019 127.992 -0.020
202307 -0.140 128.974 -0.145
202310 -0.170 129.810 -0.176
202401 -0.246 130.124 -0.253
202404 -0.268 132.289 -0.272
202407 -0.216 132.708 -0.218
202410 -0.261 133.182 -0.263
202501 -0.284 134.029 -0.284

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zeo ScientifiX  (OTCPK:ZEOX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Zeo ScientifiX Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Zeo ScientifiX's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zeo ScientifiX Business Description

Traded in Other Exchanges
N/A
Address
3321 College Avenue, Suite 246, Davie, FL, USA, 33314
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
Executives
Skycrest Holdings, Llc 10 percent owner 1930 HARRISON STREET, SUITE 204, HOLLYWOOD FL 33020
Harry L. Leider director, officer: CEO and Director C/O GELESIS, INC., 501 BOYLSTON STREET, SUITE 6102, BOSTON MA 02116
Howard Lawrence Golub officer: Executive Vice President & CSO 23648 SEPTEMBER SUN SQ, ASHBURN VA 20148
Matthew Phillip Sinnreich officer: COO and Acting CEO 4045 SHERIDAN AVENUE, SUITE 239, MIAMI BEACH FL 33139
Steven Jerry Glauser director 1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131
Leathem S Stearn director 2306 BAY DRIVE, POMPANO BEACH FL 33062
Charles Luther Bretz director 58 N. CHICAGO ST, 2ND FLOOR, JOLIET IL 60432
Bhupendra Kumar Modi director 6 MARINA BOULEVARD, #63-18, THE SALE @ MARINA BAY U0 018985
Gurvinder Pal Singh director E - 128, FIRST FLOOR, GREATER KAILASH - II, NEW DELHI K7 110048
John F Chiste director
Ryan C Likes officer: Chief Operating Officer 1116 MEADOWBROOK AVE., LOS ANGELES CA 90019
Greyt Ventures, Llc 10 percent owner GREYT VENTURES, LLC, 20533 BISCAYNE BOULEVARD, SUITE 648, AVENTURA FL 33180
Wendy Grey 10 percent owner GREYT VENTURES, LLC, 20533 BISCAYNE BOULEVARD, SUITE 648, AVENTURA FL 33180
Ian T Bothwell 10 percent owner, officer: Chief Financial Officer 77 530 ENFIELD LANE, BLDG D, PALM DESERT CA 92211
Albert Mitrani director, officer: Chief Executive Officer 4045 SHERIDAN AVE., SUITE 239, MIAMI BEACH FL 33140